Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary

Nicholas A Pullen1 School of Biological Sciences, University of Northern Colorado, Greeley, CO, USA

Andrew R Pickford2 Biophysics Laboratories, School of Biological Sciences, Institute of Biological and Biomedical Sciences, University of Portsmouth

Mark M Perry3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Diane M Jaworski4 Department of Neurological Sciences, Robert Larner College of Medicine, University of Vermont, Burlington, VT

Katie F Loveson3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Daniel J Arthur3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Jonathan R Holliday3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Timothy E Van Meter5 Department of Pediatrics, Pediatric Hematology–Oncology, VCU School of Medicine, Richmond, VA, USA

Ritchie Peckham3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Waqar Younas3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Sophie EJ Briggs6 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada

Sophie MacDonald3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Thomas Butterfield3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Myrianni Constantinou3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Helen L Fillmore3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UKCorrespondence[email protected]

Articles from other publishers (9)